Open AccessDoes Doxycycline Protect Against Development of Clostridium difficile Infection?
Author(s) -
Sarah B. Doernberg,
Lisa G. Winston,
Daniel Deck,
Henry F. Chambers
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis457
Subject(s) - doxycycline , medicine , clostridium difficile , antibiotics , ceftriaxone , risk factor , microbiology and biotechnology , intensive care medicine , biology
Receipt of antibiotics is a major risk factor for Clostridium difficile infection (CDI). Doxycycline has been associated with a lower risk for CDI than other antibiotics. We investigated whether doxycycline protected against development of CDI in hospitalized patients receiving ceftriaxone, a high-risk antibiotic for CDI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom